Stay updated on Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for a Phase 1 study of cabozantinib plus pemetrexed for several advanced cancers. It includes study status and dates, participant criteria, treatment details, and measured outcomes.
    Difference
    42%
    Check dated 2026-11-08T13:50:32.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study page remains a 403 Forbidden error page. Its footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.3%
    Check dated 2026-11-01T15:09:27.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A banner announces an NIH-wide transition notice, including updated terminology for artificial intelligence.
    Difference
    1%
    Check dated 2026-10-25T14:08:25.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T14:15:19.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains an error page showing a 403 Forbidden message; its footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T15:15:01.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Access to the NCT04173338 study record is replaced by a 403 Forbidden error, removing the study details and related content from the page. This change alters how users view the trial information by displaying an access-denied page instead of the study record.
    Difference
    17%
    Check dated 2026-09-20T20:09:52.000Z thumbnail image

Stay in the know with updates to Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.